Medical AMMetal Additive ManufacturingMoney & Funding

Zeda closes US$52 million series B financing round

The funding will primarily be used for medical product expansion in the US and Asia

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Zeda, Inc. (previously PrinterPrezz/Vertex Manufacturing), a leader in advanced 3D manufacturing and nanotech solutions for the medical, space, aerospace, and defense industries, has closed a $52 million equity and debt financing for a total capital raise of $68 million, to date.

The Series B round included the participation of multiple new institutional and strategic investors, including  Michelin, Taiyo Nippon Sanso Corporation (a Mitsubishi Chemical Group company), and Fives Group. It was jointly led by existing investors – Boutique Venture Partners, Berkeley Catalyst Fund, DOV Management, and Solvay Ventures.

Zeda closes US$52 million series B financing round. The funding will primarily be used for medical product expansion in the US and Asia.
Shri Shetty, CEO of Zeda.

The company will primarily use the proceeds to fund its new advanced manufacturing digital foundry in  Cincinnati, Ohio, as well as expand its facilities – globally – to address the growth in demand for metal 3D  printing in medical, space, aerospace, defense, and energy applications, as well as expansion into the Asian market for its medical implant applications. This follows last year’s announcement of an agreement with the Singapore Healthcare Clusters and the National Additive Manufacturing Innovation Cluster (NAMIC) to grow the 3D printed implant market in the region.

“Zeda is seeing exponential growth in our served markets, driven by our regulated-industry partners and products, due to the global environment and localizing of supply chains. We are delighted to have closed a substantial round, particularly with the current economic headwinds. This further validates our vision for the company and the capabilities of our exceptional team to execute against our business plan,” said Shri Shetty, CEO of Zeda.

“We’re delighted to continue to support Zeda in their Series B round. What impresses me most about the company is its ability to provide a complete solution for medical devices from concept to production – dramatically speeding innovation,” said Dr. Rami El Assal, Managing General Partner and Co-founder of Boutique Venture Partners, which specializes in early-stage investments in life sciences and healthcare.

“As this funding round shows, there is a market even in tough times for industry leaders like Zeda. Few challenges are as complex as revitalizing localized manufacturing and securing critical supply chains. We’re pleased to invest in Zeda as we believe, leveraging advanced manufacturing and technology, it’s best positioned to deliver reliable, high-quality products across multiple regulated industries and applications,” said David You, Founder and CEO of DOV Management.

“We are very excited to be a partner of Zeda and are impressed with Zeda’s quality control system for printed implants. We also believe that TNSC’s technologies, including purity control of printing atmosphere and surface modification of printed parts, will further enhance Zeda’s process,” said Mr. Kobayashi, Head of the Corporate Office of Innovation at Taiyo Nippon Sanso Corporation (a Mitsubishi Chemical Group company).

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.